MACK DAVID HENRY (President and CEO) sold 9.8% of their position (58.41K shares) of PMV PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $62.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/3/2025ACC: 0001415889-25-019380
DirectorOfficer· President and CEO
Since Sep 2020
-58.41K
Net shares
Net seller
$62.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
58.41K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−58.41K
Price / share
$1.06
Trade value
$62.18K
% of position
9.8%
7/1/2025
594.54K→536.13K
Total
Net shares
−58.41K
Net value
-$62.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2025 | S · Sale | −58.41K | $1.06 | $62.18K | 9.8% | 594.54K | 536.13K |
| Total | −58.41K | -$62.18K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned165.31K
Common Stock
IndirectShares owned147.91K
Common Stock
IndirectShares owned56.98K
Total
370.20K indirect370.20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 165.31K | Indirect |
| Common Stock | 147.91K | Indirect |
| Common Stock | 56.98K | Indirect |
| Total | 370.20K | 370.20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported